These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 6117947

  • 21. Striatal dopamine receptor supersensitivity after long-term haloperidol treatment of hypophysectomized rats.
    DeLucia R, Scavone C, Camillo MA.
    Braz J Med Biol Res; 1989; 22(6):741-3. PubMed ID: 2620186
    [Abstract] [Full Text] [Related]

  • 22. A comparative study of [3H]haloperidol and [3H]spiroperidol binding to receptors on rat cerebral membranes.
    Howlett DR, Nahorski SR.
    FEBS Lett; 1978 Mar 01; 87(1):152-6. PubMed ID: 631328
    [No Abstract] [Full Text] [Related]

  • 23. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors.
    Tachizawa H, Sudo K, Sano M.
    Eur J Pharmacol; 1979 Nov 16; 59(3-4):245-51. PubMed ID: 43256
    [Abstract] [Full Text] [Related]

  • 24. Effect of cyclo(leucyl-glycine) on [3H]spiroperidol binding in the corpus striatum and hypothalamus of spontaneously hypertensive rats.
    Bhargava HN.
    Eur J Pharmacol; 1984 Apr 13; 100(1):109-12. PubMed ID: 6723774
    [Abstract] [Full Text] [Related]

  • 25. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA, Altar CA, Wong CA, Marshall JF.
    Brain Res; 1984 Jun 04; 302(1):9-18. PubMed ID: 6428705
    [Abstract] [Full Text] [Related]

  • 26. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP, Wooten GF.
    Ann Neurol; 1986 Apr 04; 19(4):378-83. PubMed ID: 3707090
    [Abstract] [Full Text] [Related]

  • 27. Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum.
    Allen RM, Lane JD, Brauchi JT.
    Eur J Pharmacol; 1980 Jul 25; 65(2-3):313-5. PubMed ID: 7190503
    [Abstract] [Full Text] [Related]

  • 28. 77Br-p-bromospiperone: a ligand for in vivo labelling of dopamine receptors.
    Owen F, Poulter M, Mashal RD, Crow TJ, Veall N, Zanelli GD.
    Life Sci; 1983 Aug 22; 33(8):765-8. PubMed ID: 6888192
    [Abstract] [Full Text] [Related]

  • 29. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S, Robson PA.
    Neuropharmacology; 1981 Dec 22; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract] [Full Text] [Related]

  • 30. Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors.
    Hess EJ, Norman AB, Creese I.
    J Neurosci; 1988 Jul 22; 8(7):2361-70. PubMed ID: 2907912
    [Abstract] [Full Text] [Related]

  • 31. Binding of [3H]spiroperidol to striatal membranes of rats treated chronically with morphine. Influence of Pro-Leu-Gly-NH2 and cyclo(Leu-Gly).
    Bhargava HN.
    Neuropharmacology; 1983 Dec 22; 22(12A):1357-61. PubMed ID: 6141535
    [Abstract] [Full Text] [Related]

  • 32. Regional blockade by neuroleptic drugs of in vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies.
    Köhler C, Haglund L, Ogren SO, Angeby T.
    J Neural Transm; 1981 Dec 22; 52(3):163-73. PubMed ID: 7198139
    [Abstract] [Full Text] [Related]

  • 33. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA, Magistretti PJ, Shoemaker WJ, Deyo SN, Bloom FE.
    Brain Res; 1982 Jan 28; 232(2):401-12. PubMed ID: 6322915
    [Abstract] [Full Text] [Related]

  • 34. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.
    Sibley DR, Weinberger S, Segal DS, Creese I.
    Experientia; 1982 Oct 15; 38(10):1224-5. PubMed ID: 6890464
    [No Abstract] [Full Text] [Related]

  • 35. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation.
    Korf J, Sebens JB.
    J Neurochem; 1987 Feb 15; 48(2):516-21. PubMed ID: 2878979
    [Abstract] [Full Text] [Related]

  • 36. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
    Schweitzer JW, Schwartz R, Friedhoff AJ.
    Res Commun Chem Pathol Pharmacol; 1982 Oct 15; 38(1):21-30. PubMed ID: 7146618
    [Abstract] [Full Text] [Related]

  • 37. Early supersensitive changes in [3H] spiroperidol binding in the isolated striatum.
    Csernansky JG, Friedhoff AJ, Bonnet KA.
    Biochem Biophys Res Commun; 1982 Mar 15; 105(1):117-20. PubMed ID: 6124243
    [No Abstract] [Full Text] [Related]

  • 38. Enhanced [3H]spiroperidol binding in striatum of spontaneously hypertensive rat (SHR).
    Chiu P, Rajakumar G, Chiu S, Kwan CY, Mishra RK.
    Eur J Pharmacol; 1982 Aug 27; 82(3-4):243-4. PubMed ID: 7128691
    [No Abstract] [Full Text] [Related]

  • 39. Effects of alloxan-induced diabetes on dopaminergic receptors in rat striatum and anterior pituitary.
    Serri O, Renier G, Somma M.
    Horm Res; 1985 Aug 27; 21(2):95-101. PubMed ID: 3979949
    [Abstract] [Full Text] [Related]

  • 40. L-prolyl-l-leucyl-glycinamide and its peptidomimetic analog 3(R)-[(2(S)-pyrrolidylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide (PAOPA) attenuate haloperidol-induced c-fos expression in the striatum.
    Ott MC, Costain WJ, Mishra RK, Johnson RL.
    Peptides; 2000 Feb 27; 21(2):301-8. PubMed ID: 10764960
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.